keyword
https://read.qxmd.com/read/38614649/assessment-and-management-of-chronic-kidney-disease-in-people-living-with-obesity
#21
JOURNAL ARTICLE
Peter Jacob, Kieran McCafferty
Obesity and chronic kidney disease (CKD) are common and frequently coexisting medical conditions. Already well known to be a risk factor for type 2 diabetes mellitus (T2DM), ischaemic heart disease, stroke, hypertension, malignancy and premature death, obesity also predisposes to CKD. Elevated weight leads to declining renal function through several mechanisms, including established pathways via metabolic syndrome, hypertension and T2DM, but also through relatively recently understood glomerulosclerosis, directly related to obesity...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614011/multimodal-detection-and-analysis-of-microplastics-in-human-thrombi-from-multiple-anatomically-distinct-sites
#22
JOURNAL ARTICLE
Tingting Wang, Zhiheng Yi, Xiaoqiang Liu, Yuxin Cai, Xianxi Huang, Jingnian Fang, Ronghuai Shen, Weikun Lu, Yingxiu Xiao, Weiduan Zhuang, Shaowei Guo
BACKGROUND: Microplastic (MP) pollution has emerged as a significant environmental concern worldwide. While extensive research has focused on their presence in marine organisms and ecosystems, their potential impact on human health, particularly on the circulatory system, remains understudied. This project aimed to identify and quantify the mass concentrations, polymer types, and physical properties of MPs in human thrombi surgically retrieved from both arterial and venous systems at three anatomically distinct sites, namely, cerebral arteries in the brain, coronary arteries in the heart, and deep veins in the lower extremities...
April 12, 2024: EBioMedicine
https://read.qxmd.com/read/38609322/risk-of-extended-major-adverse-cardiovascular-event-endpoints-with-tofacitinib-versus-tnf-inhibitors-in-patients-with-rheumatoid-arthritis-a-post-hoc-analysis-of-a-phase-3b-4-randomised-safety-study
#23
RANDOMIZED CONTROLLED TRIAL
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
OBJECTIVES: Compare the risk of extended major adverse cardiovascular (CV) event (MACE) composite outcomes and component events in patients with rheumatoid arthritis (RA) treated with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in Oral Rheumatoid Arthritis Trial (ORAL) Surveillance. METHODS: Patients with RA aged ≥50 years and with ≥1 additional CV risk factor received tofacitinib 5 mg or 10 mg two times per day or TNFi...
April 12, 2024: RMD Open
https://read.qxmd.com/read/38606645/cause-specific-death-in-heart-failure-across-the-ejection-fraction-spectrum-a-comprehensive-assessment-of-over-100%C3%A2-000-patients-in-the-swedish-heart-failure-registry
#24
JOURNAL ARTICLE
Camilla Settergren, Lina Benson, Angiza Shahim, Ulf Dahlström, Tonje Thorvaldsen, Gianluigi Savarese, Lars H Lund, Bahira Shahim
AIM: To assess cause-specific death in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction (HFpEF, HFmrEF, and HFrEF). METHODS AND RESULTS: Data were analysed from the Swedish Heart Failure Registry (SwedeHF) and the National Patient Register of patients enrolled in SwedeHF 2000-2021. Cox proportional hazards regression models were performed and adjusted for age, sex and time period. Among 100 584 patients (23% HFpEF, 23% HFmrEF, 53% HFrEF), median age (interquartile range) was 75 (66-82) and 36% were female...
April 12, 2024: European Journal of Heart Failure
https://read.qxmd.com/read/38604747/safety-and-effectiveness-of-glycoprotein-iib-iiia-inhibitors-in-acute-coronary-syndromes-insights-from-the-spum-acs-study
#25
JOURNAL ARTICLE
Francesco Bruno, Florian A Wenzl, Ovidio De Filippo, Simon Kraler, Federico Giacobbe, Marco Roffi, Olivier Muller, Lorenz Räber, Christian Templin, Gaetano Maria De Ferrari, Fabrizio D'Ascenzo, Thomas F Lüscher
AIMS: Data on Glycoprotein IIb/IIIa inhibitors (GPI) use in real world ACS patients following the introduction of potent P2Y12 inhibitors and newer generation stents are scant. Here, we aimed to assess the utilization, effectiveness, and safety of GPI in a large prospective multi-centre cohort of contemporary ACS patients. METHODS AND RESULTS: SPUM-ACS prospectively recruited patients presenting with ACS between 2009 and 2017. The primary endpoint of the present study was major adverse cardiovascular events (MACE), a composite of all-cause death, non-fatal myocardial infarction (MI) and non-fatal stroke at one year...
April 11, 2024: European Heart Journal. Cardiovascular Pharmacotherapy
https://read.qxmd.com/read/38604209/coronary-sinus-reducer-for-the-treatment-of-refractory-angina-orbita-cosmic-a-randomised-placebo-controlled-trial
#26
JOURNAL ARTICLE
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, Florentina A Simader, Shayna Chotai, Rachel H Pathimagaraj, Muhammad Mohsin, Ahmed Salih, Danqi Wang, Prithvi Dixit, John R Davies, Tom R Keeble, Claudia Cosgrove, James C Spratt, Peter D O'Kane, Ranil De Silva, Jonathan M Hill, Sukhjinder S Nijjer, Sayan Sen, Ricardo Petraco, Ghada W Mikhail, Ramzi Khamis, Tushar Kotecha, Frank E Harrell, Peter Kellman, Darrel P Francis, James P Howard, Graham D Cole, Matthew J Shun-Shin, Rasha K Al-Lamee
BACKGROUND: The coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable coronary artery disease by improving myocardial perfusion. We aimed to measure its efficacy, compared with placebo, on myocardial ischaemia reduction and symptom improvement. METHODS: ORBITA-COSMIC was a double-blind, randomised, placebo-controlled trial conducted at six UK hospitals. Patients aged 18 years or older with angina, stable coronary artery disease, ischaemia, and no further options for treatment were eligible...
April 4, 2024: Lancet
https://read.qxmd.com/read/38597064/the-clinical-value-of-%C3%AE-blockers-in-patients-with-stable-angina
#27
REVIEW
Paolo Palatini, Jose R Faria-Neto, Raul D Santos
Stable angina, one manifestation of chronic coronary syndrome (CCS), is characterised by intermittent episodes of insufficient blood supply to the myocardium, provoking symptoms of myocardial ischaemia, particularly chest pain. These attacks usually occur during exercise or stress. Anti-ischaemic drugs are the mainstay of pharmacologic management of CCS with symptoms of angina. β-blockers reduce heart rate and myocardial contractility, thus reducing myocardial oxygen consumption. These drugs have been shown to ameliorate the frequency of anginal attacks and to improve exercise capacity in these patients...
2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38595039/evaluation-of-comorbidity-scoring-systems-in-patients-undergoing-knee-arthroplasty
#28
JOURNAL ARTICLE
Alexander Green, Jonathan Old, Oday Al-Dadah
BACKGROUND: Ageing populations are increasing the demand for knee arthroplasty. Concurrently, the prevalence of medical comorbidities are rising too. The Self-Administered Comorbidity Questionnaire was developed to provide a patient's assessment of their own comorbidities whereas the American Society of Anesthesiologists grades and the Charlson Comorbidity Index utilise clinical evaluation to objectively measure perioperative morbidity and mortality risk. The primary aim of this study was to compare Self-Administered Comorbidity Questionnaire scores with American Society of Anesthesiologists grades and Charlson Comorbidity Index scores...
April 9, 2024: Journal of Perioperative Practice
https://read.qxmd.com/read/38594599/improving-outcomes-in-atherosclerotic-renovascular-disease-importance-of-clinical-presentation-and-multi-disciplinary-review
#29
JOURNAL ARTICLE
Áine M de Bhailis, Edward Lake, Constantina Chrysochou, Darren Green, Rajkumar Chinnadurai, Philip A Kalra
BACKGROUND AND OBJECTIVES: Atherosclerotic renal artery stenosis may cause hypertension, chronic kidney disease and heart failure, but large randomized control trials to date have shown no major additional benefit of renal revascularization over optimal medical management. However, these trials did not consider outcomes specifically in relation to clinical presentations. Given that atherosclerotic renal artery stenosis is a heterogenous condition, measures of success likely differ according to the clinical presentation...
April 9, 2024: Journal of Nephrology
https://read.qxmd.com/read/38594057/risk-of-cardiovascular-disease-with-high-dose-versus-low-dose-use-of-non-steroidal-anti-inflammatory-drugs-in-ankylosing-spondylitis
#30
JOURNAL ARTICLE
Ji-Won Kim, Jun Sik Yoon, Sojeong Park, Hasung Kim, Ji Sung Lee, Jung-Yoon Choe
OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) associated with increasing dose of a non-steroidal anti-inflammatory drug (NSAID) in patients with ankylosing spondylitis (AS). METHODS: Using the Korean National Health Insurance database, patients newly diagnosed with AS without prior CVD between 2010 and 2018 were included in this nationwide cohort study. The primary outcome was CVD, a composite outcome of ischaemic heart disease, stroke or congestive heart failure...
April 9, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38592444/atrial-fibrillation-age-at-diagnosis-incident-cardiovascular-events-and-mortality
#31
JOURNAL ARTICLE
Christian Paludan-Müller, Oliver B Vad, Niels K Stampe, Søren Z Diederichsen, Laura Andreasen, Laia M Monfort, Emil L Fosbøl, Lars Køber, Christian Torp-Pedersen, Jesper H Svendsen, Morten S Olesen
BACKGROUND AND AIMS: Patients with atrial fibrillation (AF) are at increased risks of cardiovascular diseases and mortality, but risks according to age at diagnosis have not been reported. This study investigated age-specific risks of outcomes among patients with AF and the background population. METHODS: This nationwide population-based cohort study included patients with AF and controls without outcomes by the application of exposure density matching on the basis of sex, year of birth, and index date...
April 9, 2024: European Heart Journal
https://read.qxmd.com/read/38591289/challenges-and-technical-aspects-in-the-management-of-muscle-invasive-bladder-cancer-as-retrograde-radical-cystectomy-with-ileal-conduit
#32
JOURNAL ARTICLE
Nadeem Bin Nusrat, Assad Ur Rehman, Nauman Zafar, Shujah Muhammad, Sarmad Imtiaz Bajwa, Saira Imtiaz
OBJECTIVE: To evaluate long-term outcomes in patients homogenously treated with radical cystectomy and ileal conduit for muscle invasive bladder cancer. METHODS: The retrospective study was conducted at the Urology Department of Pakistan Kidney and Liver Institute and Research Centre, Lahore, Pakistan, and comprised data from December 25, 2017, to January 16, 2023, related to patients who underwent radical cystectomy with ileal conduit with or without neo-adjuvant and adjuvant radiation, chemotherapy, or immunotherapy for papillary urothelial carcinom of the bladder...
March 2024: JPMA. the Journal of the Pakistan Medical Association
https://read.qxmd.com/read/38589018/global-burden-of-cardiovascular-disease-attributable-to-smoking-1990-2019-an-analysis-of-the-2019-global-burden-of-disease-study
#33
JOURNAL ARTICLE
Abdul Mannan Khan Minhas, Ramy Sedhom, Estelle D Jean, Michael D Shapiro, Julio A Panza, Mahboob Alam, Salim S Virani, Christie M Ballantyne, Dmitry Abramov
AIMS: This study aims to investigate the trends in the global cardiovascular disease (CVD) burden attributable to smoking from 1990 to 2019. METHODS AND RESULTS: Global Burden of Disease Study 2019 was used to analyse the burden of CVD attributable to smoking (i.e. ischaemic heart disease, peripheral artery disease, stroke, atrial fibrillation and flutter, and aortic aneurysm). Age-standardized mortality rates (ASMRs) per 100 000 and age-standardized disability-adjusted life year rates (ASDRs) per 100 000, as well as an estimated annual percentage change (EAPC) in ASMR and ASDR, were determined by age, sex, year, socio-demographic index (SDI), regions, and countries or territories...
April 9, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38588997/biomaterials-for-direct-cardiac-repair-a-rapid-scoping-review-2012-2022
#34
REVIEW
Veronika Sedláková, Sophia Mourcos, Justina Pupkaitė, Yvonne Lunn, Sarah Visintini, Irene Guzman-Soto, Marc Ruel, Erik Suuronen, Emilio I Alarcon
A plethora of biomaterials for heart repair are being tested worldwide for potential clinical application. These therapeutics aim to enhance the quality of life of patients with heart disease using various methods to improve cardiac function. Despite the myriad of therapeutics tested, only a minority of these studied biomaterials have entered clinical trials. This rapid scoping review aims to analyze literature available from 2012 to 2022 with a focus on clinical trials using biomaterials for direct cardiac repair, i...
April 6, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38584180/risk-of-diabetic-retinopathy-and-diabetic-macular-oedema-with-sodium-glucose-cotransporter-2-inhibitors-and-glucagon-like-peptide-1-receptor-agonists-in-type-2-diabetes-a-real-world-data-study-from-a-global-federated-database
#35
JOURNAL ARTICLE
Aikaterini Eleftheriadou, David Riley, Sizheng S Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
AIMS/HYPOTHESIS: A protective role of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic retinopathy and diabetic macular oedema has been described in some recent studies, which may extend beyond glycaemic control. We aimed to review the clinical impact of SGLT2i and GLP1-ra therapy on the risk of diabetic retinopathy and diabetic macular oedema in individuals with type 2 diabetes taking insulin. METHODS: This is a retrospective cohort analysis of approximately two million people with type 2 diabetes receiving insulin across 97 healthcare organisations using a global federated health research network (TriNetX, Cambridge, USA)...
April 8, 2024: Diabetologia
https://read.qxmd.com/read/38582530/the-complex-interaction-between-cancer-ischaemic-heart-disease-and-heart-failure-and-a-focus-on-arrhythmias-including-risk-stratification-in-brugada-syndrome-and-leadless-pacing
#36
JOURNAL ARTICLE
https://read.qxmd.com/read/38582094/global-burden-of-288-causes-of-death-and-life-expectancy-decomposition-in-204-countries-and-territories-and-811-subnational-locations-1990-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021
#37
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations...
April 3, 2024: Lancet
https://read.qxmd.com/read/38579320/haemoglobin-thresholds-for-transfusion-how-are-we-doing-in-the-era-of-choosing-wisely-a-retrospective-cohort-study
#38
JOURNAL ARTICLE
Phyranavy Jeganathan-Udayakumar, Nicole Tochtermann, Thomas Beck, Maria M Wertli, Christine Baumgartner
INTRODUCTION:  Clinical practice guidelines and the Choosing Wisely initiative launched in 2012 recommend a haemoglobin (Hb) threshold of 70-80 g/lfor red blood cell (RBC) transfusions in stable hospitalised patients. Data on transfusion practices and their trends in medical inpatients are limited. To address this gap, we investigated transfusion practices and their trends in general internal medicine and other clinics. METHODS: This retrospective cohort study analysed data from all hospitalisations with RBC transfusions at a Swiss university hospital between 2012 and 2019...
November 29, 2023: Swiss Medical Weekly
https://read.qxmd.com/read/38572088/correlates-and-consequences-of-atrial-fibrillation-in-a-prospective-study-of-25-000-participants-in-the-china-kadoorie-biobank
#39
JOURNAL ARTICLE
Iain Turnbull, Christian Fielder Camm, Jim Halsey, Huaidong Du, Derrick A Bennett, Yiping Chen, Canqing Yu, Dianyianji Sun, Xiaohong Liu, Liming Li, Zhengming Chen, Robert Clarke
AIMS: The prevalence of atrial fibrillation (AF) is positively correlated with prior cardiovascular diseases (CVD) and CVD risk factors but is lower in Chinese than Europeans despite their higher burden of CVD. We examined the prevalence and prognosis of AF and other electrocardiogram (ECG) abnormalities in the China Kadoorie Biobank. METHODS AND RESULTS: A random sample of 25 239 adults (mean age 59.5 years, 62% women) had a 12-lead ECG recorded and interpreted using a Mortara VERITAS™ algorithm in 2013-14...
March 2024: Eur Heart J Open
https://read.qxmd.com/read/38570261/prevalence-and-predictors-of-emergency-medical-service-use-in-patients-undergoing-primary-percutaneous-coronary-intervention-for-st-elevation-myocardial-infarction
#40
JOURNAL ARTICLE
Arul Baradi, Diem T Dinh, Angela Brennan, Dion Stub, Jithendra Somaratne, Sonny Palmer, Ziad Nehme, Emily Andrew, Karen Smith, Danny Liew, Christopher M Reid, Jeffrey Lefkovits, Andrew Wilson
AIM: We aim to describe prevalence of Emergency Medical Service (EMS) use, investigate factors predictive of EMS use, and determine if EMS use predicts treatment delay and mortality in our ST-elevation myocardial infarction (STEMI) cohort. METHOD: We prospectively collected data on 5,602 patients presenting with STEMI for primary percutaneous coronary intervention (PCI) transported to PCI-capable hospitals in Victoria, Australia, from 2013-2018 who were entered into the Victorian Cardiac Outcomes Registry (VCOR)...
April 2, 2024: Heart, Lung & Circulation
keyword
keyword
63558
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.